Moderna's coronavirus vaccine shows promise in older adults

Researchers said Tuesday that Moderna's coronavirus vaccine candidate produced virus-neutralizing antibodies in older adults that were similar to levels in younger adults, Reuters reports. The study, published in the New England Journal of Medicine, also found that side effects from the vaccine were similar to those from high-dose flu shots. The side effects included headache, fatigue, body aches, and chills. "They might feel off or have a fever," said Dr. Evan Anderson, one of the study's lead researchers from Emory University in Atlanta. Anderson said the findings were reassuring, because immunity normally weakens with age. Moderna is testing the higher doses it researched in a large Phase III trial, the last hurdle before it can request emergency authorization or approval.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up